Similarly, the demethylase ALKBH5 demonstrates opposing functions in HCC: it inhibits malignancy and progression [61] in certain cases and promotes oncogenesis [133] by stabilizing pro-oncogenic mRNA in HBV-related HCC. Here, MBD2 is linked to hepatocellular carcinoma.